Milestone Pharmaceuticals Inc (MIST)
1.74
-0.01
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
1.74
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Price to Book Value: 2.321 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.321 |
| May 16, 2024 | 2.335 |
| May 15, 2024 | 2.308 |
| May 14, 2024 | 2.295 |
| May 13, 2024 | 2.268 |
| May 10, 2024 | 2.267 |
| May 09, 2024 | 2.267 |
| May 08, 2024 | 2.267 |
| May 07, 2024 | 2.321 |
| May 06, 2024 | 2.321 |
| May 03, 2024 | 2.254 |
| May 02, 2024 | 2.187 |
| May 01, 2024 | 2.134 |
| April 30, 2024 | 2.201 |
| April 29, 2024 | 2.094 |
| April 26, 2024 | 2.054 |
| April 25, 2024 | 2.107 |
| April 24, 2024 | 2.214 |
| April 23, 2024 | 2.267 |
| April 22, 2024 | 2.174 |
| April 19, 2024 | 2.187 |
| April 18, 2024 | 2.174 |
| April 17, 2024 | 2.334 |
| April 16, 2024 | 2.347 |
| April 15, 2024 | 2.341 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.307 |
| April 11, 2024 | 2.261 |
| April 10, 2024 | 2.227 |
| April 09, 2024 | 2.227 |
| April 08, 2024 | 2.428 |
| April 05, 2024 | 2.401 |
| April 04, 2024 | 2.334 |
| April 03, 2024 | 2.347 |
| April 02, 2024 | 2.401 |
| April 01, 2024 | 2.441 |
| March 28, 2024 | 5.673 |
| March 27, 2024 | 5.704 |
| March 26, 2024 | 5.736 |
| March 25, 2024 | 5.483 |
| March 22, 2024 | 5.514 |
| March 21, 2024 | 4.944 |
| March 20, 2024 | 4.754 |
| March 19, 2024 | 4.595 |
| March 18, 2024 | 4.722 |
| March 15, 2024 | 4.595 |
| March 14, 2024 | 4.500 |
| March 13, 2024 | 4.595 |
| March 12, 2024 | 4.706 |
| March 11, 2024 | 4.880 |
| March 08, 2024 | 4.785 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3633
Minimum
Mar 24 2020
5.736
Maximum
Mar 26 2024
2.236
Average
2.093
Median
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3909 |
| Aurinia Pharmaceuticals Inc | 2.180 |
| Edesa Biotech Inc | 3.384 |
| Lexaria Bioscience Corp | 6.225 |
| Xenon Pharmaceuticals Inc | 3.384 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0387 |
| Price | 1.74 |
| Earnings Yield | -71.84% |
| Market Cap | 92.67M |
| PEGY Ratio | -0.0387 |